|
Volumn 22, Issue 3, 2001, Pages 217-220
|
Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations
a a a a a |
Author keywords
Endometrial carcinoma; Fertility; Medroxyprogesterone acetate
|
Indexed keywords
MEDROXYPROGESTERONE ACETATE;
ACANTHOMA;
ADENOCARCINOMA;
ADULT;
CANCER CHEMOTHERAPY;
CANCER GRADING;
CANCER RECURRENCE;
CANCER REGRESSION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG RESPONSE;
ENDOMETRIOID CARCINOMA;
ENDOMETRIUM CARCINOMA;
FEMALE;
FEMALE FERTILITY;
FOLLOW UP;
HUMAN;
ORGAN PRESERVATION;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ADULT;
ANTINEOPLASTIC AGENTS, HORMONAL;
ENDOMETRIAL NEOPLASMS;
FEMALE;
FERTILITY;
HUMANS;
JAPAN;
MEDROXYPROGESTERONE 17-ACETATE;
PROGNOSIS;
TREATMENT OUTCOME;
|
EID: 0034885881
PISSN: 03922936
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (90)
|
References (19)
|